With regard to human health, the Authority found, based on the Opinion of the Scientific Committee on Food concerning capsaicin [Opinion of the Scientific Committee on Food on Capsaicin; Scientific Committee on Food SCF/CS/FLAV/FLAVOUR/8, 26 February 2002.], that capsaicinoids are known to be genotoxic in vivo and in vitro and adverse health effects are known to occur following their oral intake by humans. Therefore, in May 2025, the Commission mandated the Authority to issue a scientific opinion on the health risks related to the presence of capsaicin in foods [Further details and related timelines available in OpenEFSA: https://open.efsa.europa.eu/questions/EFSA-Q-2025-00304?search=capsaicin.]. Furthermore, the Authority identified a data gap as regards genotoxicity assessment and could not finalise the non-dietary risk assessment, nor the consumer risk assessment because the respective toxicological reference values were not available. Consequently, the Commission concludes that it is not possible to demonstrate the fulfilment of the condition set out in Article 23(1), points (a) and (b), of Regulation (EC) No 1107/2009, that an active substance is not a substance of concern, and that it does not have an inherent capacity to cause endocrine-disrupting, neurotoxic or immunotoxic effects.
Recital 7, Regulation (EU) 2026/1209
In forcesince 9 Jun 2026